QR Code

The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review

Abstract Background The adoption of immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) and/or local therapy, including transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC), has been utilized as neoadjuvant or conversion therapy for...

Description complète

Enregistré dans:
Auteurs principaux: Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang
Format: Artigo
Langue:Inglês
Publié: BMC 2025-12-01
Collection:BMC Cancer
Sujets:
Immune checkpoint inhibitors
Conversion therapy
Neoadjuvant therapy
Hepatocellular carcinoma
Liver resection
Accès en ligne:https://doi.org/10.1186/s12885-025-15449-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires